Workflow
蓝丰生化拟回购注销部分限制性股票,因业绩考核未达标

Core Viewpoint - Jiangsu Lanfeng Bio-chemical Co., Ltd. plans to repurchase and cancel a portion of restricted stocks due to unmet performance targets for the year 2024 [1] Group 1: 2021 Incentive Plan Overview - The 2021 incentive plan was approved on December 31, 2021, with 33.95 million restricted stocks granted at a price of 3.00 CNY per share [2] - A total of 33.85 million shares were actually granted to 55 recipients, representing approximately 9.95% of the company's total share capital before the grant [2] - Subsequent repurchases and cancellations occurred on April 25, November 13, 2023, and April 28, 2024, with 21,012,000 shares repurchased by June 21, 2024, leaving 990,000 shares pending due to judicial freezes [2] Group 2: 2024 Incentive Plan Overview - The 2024 incentive plan was approved on June 28, 2024, with 22.366 million restricted stocks granted at a price of 1.80 CNY per share [3] - Ultimately, 22.356 million shares were granted to 107 recipients, accounting for 6.33% of the company's total share capital before the grant [3] Group 3: Details of the Repurchase and Cancellation - For the 2021 plan, 12,838,000 shares will be repurchased from 16 recipients at a price of 3.00 CNY per share, totaling 38,514,000 CNY plus interest [4] - For the 2024 plan, 6,633,300 shares will be repurchased from 103 recipients and 245,000 shares from 4 former employees at a price of 1.80 CNY per share, totaling 12,380,940 CNY plus interest [4] - The repurchase has received necessary approvals but requires further approval from the shareholders' meeting before proceeding with the cancellation and related procedures [4]